Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00644657 · ClinicalTrials.gov registry record · NA
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT00644657 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 27 participants.
The verdict
NCT00644657, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.
Interventions
- DRUG Clopidogrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00644657
The ClinicalTrials.gov registry entry for NCT00644657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clopidogrel is the first listed.
NCT00644657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00644657 about?
NCT00644657 is a clinical study titled "The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization". This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagu...
What is the current status of trial NCT00644657?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2007-03. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00644657?
The interventions under investigation include: Clopidogrel (DRUG).
Who is sponsoring clinical trial NCT00644657?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.